Products
Gene Therapy Platform | AavantiBio, Inc.
Product description
AavantiBio’s core offering is a proprietary gene therapy platform utilizing adeno-associated viruses (AAVs) to deliver therapeutic genes to target cells. This platform is currently focused on developing treatments for Friedreich’s Ataxia and other rare genetic diseases.